Publications by authors named "Siyao Gu"

Understanding the physical and chemical processes at the interfaces of metals and topological insulators is crucial for the development of the next generation of topological quantum devices. Here, we report the discovery of robust superconductivity in Pd/BiSe bilayers fabricated by sputtering Pd on the surface of BiSe. Through transmission electron microscopy measurements, we identify that the observed interfacial superconductivity originates from the diffusion of Pd into BiSe.

View Article and Find Full Text PDF

Probiotics therapy has garnered significant attention in the treatment of inflammatory bowel disease (IBD). However, a large number of oral administrated probiotics are inactivated after passing through the gastric acid environment, and their ability to colonize in the intestine is also weak. Herein, this study develops a novel probiotics formulation (GM-EcN) by incorporating (EcN) into intracellularly gelated macrophages (GM).

View Article and Find Full Text PDF

The direct hydrogenation of greenhouse gas CO to higher alcohols (COH) provides a new route for the production of high-value chemicals. Due to the difficulty of C-C coupling, the formation of higher alcohols is more difficult compared to that of other compounds. In this review, we summarize recent advances in the development of multifunctional catalysts, including noble metal catalysts, Co-based catalysts, Cu-based catalysts, Fe-based catalysts, and tandem catalysts for the direct hydrogenation of CO to higher alcohols.

View Article and Find Full Text PDF

Viral myocarditis (VMC), commonly caused by coxsackievirus B3 (CVB3) infection, lacks specific treatments and leads to serious heart conditions. Current treatments, such as IFNα and ribavirin, show limited effectiveness. Herein, rather than inhibiting virus replication, this study introduces a novel cardiomyocyte sponge, intracellular gelated cardiomyocytes (GCs), to trap and neutralize CVB3 via a receptor-ligand interaction, such as CAR and CD55.

View Article and Find Full Text PDF
Article Synopsis
  • Canagliflozin, a drug used for type 2 diabetes, has demonstrated antibacterial activity against both methicillin-sensitive and methicillin-resistant strains, showing promising inhibitory effects at specific concentrations.
  • The study indicated that canagliflozin not only enhances antibacterial effects when used with penicillin but also disrupts bacterial biofilm formation and affects bacterial metabolic processes, suggesting potential dual benefits in treating infections.
View Article and Find Full Text PDF